These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3873944)

  • 1. Systemic lupus erythematosus in a premature infant.
    Cummings NP; Hansen J; Hollister JR
    Arthritis Rheum; 1985 May; 28(5):573-5. PubMed ID: 3873944
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic lupus erythematosus.
    JAMA; 1973 Apr; 224(5 Suppl):701-11. PubMed ID: 4121550
    [No Abstract]   [Full Text] [Related]  

  • 3. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV; Holley KE; Wagoner RD; Ferguson RH; McDuffie FC
    Arthritis Rheum; 1974; 17(5):573-81. PubMed ID: 4278104
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of antinuclear antibodies with hypocomplementemia.
    Morris JL; Zizic TM; Shulman LE; Stevens MB
    Johns Hopkins Med J; 1973 Dec; 133(6):321-8. PubMed ID: 4543273
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodialysis on end-stage lupus nephritis.
    Coplon N; Siegel R; Fries J
    Trans Am Soc Artif Intern Organs; 1973; 19():302-4. PubMed ID: 4579028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systemic lupus erythematosus and antinuclear factors, with special reference to its diagnostic significance and relationship to the etiology of lupus nephritis].
    Nagasawa T
    Saishin Igaku; 1969 Oct; 24(10):2082-96. PubMed ID: 5307586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
    Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
    Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated anti-Ro/SSA thrombocytopenia: a rare feature of neonatal lupus.
    Ayadi ID; Ben Hamida E; Boukhris MR; Bezzine A; Chaouachi S; Marrakchi Z
    Pan Afr Med J; 2015; 22():312. PubMed ID: 26977221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal lupus erythematosus with cholestatic hepatitis.
    Lin SC; Shyur SD; Huang LH; Wu JY; Chuo HT; Lee HC
    J Microbiol Immunol Infect; 2004 Apr; 37(2):131-4. PubMed ID: 15181498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of nephritis following disseminated lupus erythematosus with prednisone, azathioprine and cyclophosphamide].
    Michielsen J; Go IH
    Ned Tijdschr Geneeskd; 1974 Sep; 118(37):1403-5. PubMed ID: 4606008
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of polymorphonuclear leukocyte chemotaxis by cold precipitable complexes containing DNA-anti-DNA in active nephritis of systemic lupus erythematosus.
    Losito A; Cecchini C; Pittavini L; Zampi I
    Nephron; 1982; 30(4):324-7. PubMed ID: 6981070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-associated DNA and anti-DNA antibody in systemic lupus erythematosus with nephritis.
    Frampton G; Perl S; Bennett A; Cameron JS
    Clin Exp Immunol; 1986 Mar; 63(3):621-8. PubMed ID: 3486735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of the correlation between the LE-phenomenon and antinuclear factor in systemic lupus erythematosus].
    Zhuravlev GI; Rodshteĭn OA; Shishkin VI
    Ter Arkh; 1971 Jul; 43(7):110-5. PubMed ID: 4113161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurolaryngeal manifestations in systemic lupus erythematosus].
    Alayón Fumero AC; de Serdio Arias JL
    Acta Otorrinolaringol Esp; 1994; 45(2):137-8. PubMed ID: 8086209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.
    Clark WF; Linton AL; Cordy PE; Keown PE; Lohmann RC; Lindsay RM
    Can Med Assoc J; 1978 Jun; 118(11):1391-5. PubMed ID: 350367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibody negative lupus associated with dystrophic calcification.
    Morris CN; Calobrisi SD; Matteson EL
    J Rheumatol; 1998 Apr; 25(4):825-6. PubMed ID: 9558201
    [No Abstract]   [Full Text] [Related]  

  • 19. The coexistence of Sjögren's syndrome and systemic lupus erythematosus.
    Steinberg AD; Talal N
    Ann Intern Med; 1971 Jan; 74(1):55-61. PubMed ID: 5312811
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
    Kampf D; Baethke R
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1420-3. PubMed ID: 4135099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.